M. Frueh
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 15
- Gastric Cancer Management and Outcomes 4
- Oncology 19
- Cancer Immunotherapy and Biomarkers 10
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 6
- Lung Cancer Research Studies 4
- Co-authors
- Daniel Betticher (8 shared papers)Sandro Anchisi (3 shared papers)Markus Joerger (8 shared papers)Răzvan Popescu (3 shared papers)Viviane Hess (3 shared papers)Attila Kollár (3 shared papers)Markus Borner (3 shared papers)Peter Moosmann (3 shared papers)
- Journals
- Annals of Oncology (12 papers)Journal of Clinical Oncology (11 papers)Radiotherapy and Oncology (2 papers)ESMO Open (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- SwitzerlandUnited StatesCanada
In The Last Decade
M. Frueh
28 papers receiving 315 citations
Peers
Comparison fields: 5 of 44
- Oncology 258
- Pulmonary and Respiratory Medicine 189
- Hepatology 40
- Cancer Research 43
- Geriatrics and Gerontology 5
Countries citing papers authored by M. Frueh
This map shows the geographic impact of M. Frueh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Frueh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Frueh more than expected).
Fields of papers citing papers by M. Frueh
This network shows the impact of papers produced by M. Frueh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Frueh. The network helps show where M. Frueh may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Frueh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 92 | |
| 2 | 2022 | 53 | |
| 3 | 2018 | 37 | |
| 4 | 2020 | 24 | |
| 5 | 2018 | 22 | |
| 6 | 2013 | 20 | |
| 7 | 2013 | 13 | |
| 8 | 2018 | 10 | |
| 9 | 2019 | 9 | |
| 10 | 2019 | 5 | |
| 11 | 2022 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2016 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2015 | 3 | |
| 16 | 2018 | 3 | |
| 17 | Permanent cardiac pacing in children - choosing the optimal pacing-site: a multi-centre study | 2012 | 3 |
| 18 | 2019 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2011 | 1 |
About M. Frueh
M. Frueh is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Hepatology, Molecular Biology and Cancer Research, having authored 31 papers that have together received 322 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Cancer Immunotherapy and Biomarkers (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Lung Cancer Research Studies (4 papers), Cancer Genomics and Diagnostics (4 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Oncology (258 citations), Pulmonary and Respiratory Medicine (189 citations), Hepatology (40 citations), Cancer Research (43 citations) and Geriatrics and Gerontology (5 citations). M. Frueh has collaborated with scholars based in Switzerland, United States and Canada. Frequent co-authors include Daniel Betticher, Sandro Anchisi, Markus Joerger, Răzvan Popescu, Viviane Hess, Attila Kollár, Markus Borner, Peter Moosmann, Richard Herrmann and Dieter Koeberle. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Radiotherapy and Oncology, ESMO Open and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.